A Clinical Study of a Spine Fusion System in Vertebral Body Fusion Surgery
Primary Purpose
Disc Degenerative Disease, Spondylolisthesis, Spinal Fracture
Status
Completed
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
Johnson&Johnson Medical Suzhou made Spine Fusion System
Imported EXPEDIUM screws and OPAL cage
Sponsored by
About this trial
This is an interventional treatment trial for Disc Degenerative Disease
Eligibility Criteria
Inclusion Criteria:
- 20-70 years old, male or female;
- Subject being diagnosed as having disc degeneration disease, spondylolisthesis, spinal fracture, deformity(degenerative deformity), spinal stenosis, or spinal tumor, has been treated with conservative treatment without relief or getting worse, who is suitable for surgery according to clinic practice.
- Subject is a suitable candidate for implanting investigational products described in study protocols according to investigator's assessment;
- Patient, in the opinion of the Clinical Investigator, is able to understand this clinical investigation and willing to be available for each required study procedure over the study duration.
- Subject has been given voluntary, written informed consent to participate in this clinical investigation and has authorized the transfer of his/her information to study Sponsor.
Exclusion Criteria:
- Patient has a local or systemic infection.
- Patient has had one or more previous non-fusion spinal surgery at the involved level(s).
- Patient without spinal deformity and requires fusion at 3 or more levels.
- Has been previously diagnosed with osteopenia, osteoporosis, or osteomalacia to a degree that spinal instrumentation would be contraindicated
- Has presence of active malignancy
- Has a medical condition with less than 1 year of life expectancy.
- Pregnancy or women in lactation period.
- Is grossly obese, i.e. Body Mass Index≥40.
- Has a diagnosis, which requires postoperative medication or treatment that interferes with fusion, such as steroids, chemotherapy, radiotherapy, growth factor (for more than 3 months), Nonsteroidal Antiinflammatory Drugs(for more than 3 months), and etc.
- Has history of endocrine or metabolic disorder known to affect osteogenesis (e.g. uncontrolled Diabetes with medication, renal osteodystrophy, or osteogenesis imperfect)
- Alcoholic (taking more than 40g/day, equals to 100ml 50°Chinese liquor), smoking more than 40 cigarettes/day, or Drug abuser;
- Is currently participating in another investigational drug or device study.
Sites / Locations
- Anhui Province Hospital
- Beijing Jishuitan Hospital
- Henan Provincial People's Hospital
- Jiangxi Provincial People's Hospital
- Shanghai Ruijin Hospital
- Xijing Hospital
- The First Affiliated Hospital of Xi'an Jiaotong University Medical College
- The First Affiliated Hospital of Kunming Medical College
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
China made spine fusion system
Imported spine fusion system
Arm Description
patents in this arm will be implanted with Johnson&Johnson Medical Suzhou made Spine Fusion System.
patents in this arm will be implanted with Imported EXPEDIUM screws and OPAL cage .
Outcomes
Primary Outcome Measures
Change of Japanese Orthopaedic Association score
Questionnaire
Secondary Outcome Measures
Improvement rate of Japanese Orthopaedic Association score
Questionnaire
Fixation stability
Fixation stability should be measured based on translational motion and angular motion which is demonstrated on X-Ray examination (A/P lateral, Flexion and extension).
Visual Analogue Score of low back and leg pain
Visual Analogue Scale
Wound healing
would healing are classified as 3 classes. (Class I, Class II, Class III)
Full Information
NCT ID
NCT02252185
First Posted
September 24, 2014
Last Updated
December 2, 2015
Sponsor
Johnson & Johnson Medical (Suzhou) Ltd.
1. Study Identification
Unique Protocol Identification Number
NCT02252185
Brief Title
A Clinical Study of a Spine Fusion System in Vertebral Body Fusion Surgery
Official Title
A Prospective, Multicenter, Randomized, Open-label, Controlled Study to Evaluate the Safety and Efficacy of a Spine Fusion System in Vertebral Body Fusion Surgery
Study Type
Interventional
2. Study Status
Record Verification Date
March 2015
Overall Recruitment Status
Completed
Study Start Date
July 2014 (undefined)
Primary Completion Date
September 2015 (Actual)
Study Completion Date
December 2015 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Johnson & Johnson Medical (Suzhou) Ltd.
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The primary objective of this study is to demonstrate that the efficacy and safety of Spine fusion system manufactured in China is no inferior than imported product.
Detailed Description
This study is a prospective, multicenter, randomized, comparative, non-inferiority study comparing the change of Japanese Orthopaedic Association Score from baseline at postoperative 24 weeks for patients implanted with local made Spine Fusion System versus imported products.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Disc Degenerative Disease, Spondylolisthesis, Spinal Fracture, Spinal Deformity, Spinal Stenosis, Spinal Tumor
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
106 (Actual)
8. Arms, Groups, and Interventions
Arm Title
China made spine fusion system
Arm Type
Experimental
Arm Description
patents in this arm will be implanted with Johnson&Johnson Medical Suzhou made Spine Fusion System.
Arm Title
Imported spine fusion system
Arm Type
Active Comparator
Arm Description
patents in this arm will be implanted with Imported EXPEDIUM screws and OPAL cage .
Intervention Type
Device
Intervention Name(s)
Johnson&Johnson Medical Suzhou made Spine Fusion System
Intervention Description
interventional device is Spine Fusion System that is manufactured by Johnson & Johnson Medical Suzhou Ltd.
Intervention Type
Device
Intervention Name(s)
Imported EXPEDIUM screws and OPAL cage
Intervention Description
Comparator in this study is active comparator.
Primary Outcome Measure Information:
Title
Change of Japanese Orthopaedic Association score
Description
Questionnaire
Time Frame
Preoperation and 24week post operation
Secondary Outcome Measure Information:
Title
Improvement rate of Japanese Orthopaedic Association score
Description
Questionnaire
Time Frame
7day, 12week, and 24week post operation
Title
Fixation stability
Description
Fixation stability should be measured based on translational motion and angular motion which is demonstrated on X-Ray examination (A/P lateral, Flexion and extension).
Time Frame
12week, and 24week post operation
Title
Visual Analogue Score of low back and leg pain
Description
Visual Analogue Scale
Time Frame
7day, 12week, and 24week post operation
Title
Wound healing
Description
would healing are classified as 3 classes. (Class I, Class II, Class III)
Time Frame
7day, 12week, and 24week post operation
Other Pre-specified Outcome Measures:
Title
Adverse Events
Description
Number of events
Time Frame
up to 24week post operation
10. Eligibility
Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
20-70 years old, male or female;
Subject being diagnosed as having disc degeneration disease, spondylolisthesis, spinal fracture, deformity(degenerative deformity), spinal stenosis, or spinal tumor, has been treated with conservative treatment without relief or getting worse, who is suitable for surgery according to clinic practice.
Subject is a suitable candidate for implanting investigational products described in study protocols according to investigator's assessment;
Patient, in the opinion of the Clinical Investigator, is able to understand this clinical investigation and willing to be available for each required study procedure over the study duration.
Subject has been given voluntary, written informed consent to participate in this clinical investigation and has authorized the transfer of his/her information to study Sponsor.
Exclusion Criteria:
Patient has a local or systemic infection.
Patient has had one or more previous non-fusion spinal surgery at the involved level(s).
Patient without spinal deformity and requires fusion at 3 or more levels.
Has been previously diagnosed with osteopenia, osteoporosis, or osteomalacia to a degree that spinal instrumentation would be contraindicated
Has presence of active malignancy
Has a medical condition with less than 1 year of life expectancy.
Pregnancy or women in lactation period.
Is grossly obese, i.e. Body Mass Index≥40.
Has a diagnosis, which requires postoperative medication or treatment that interferes with fusion, such as steroids, chemotherapy, radiotherapy, growth factor (for more than 3 months), Nonsteroidal Antiinflammatory Drugs(for more than 3 months), and etc.
Has history of endocrine or metabolic disorder known to affect osteogenesis (e.g. uncontrolled Diabetes with medication, renal osteodystrophy, or osteogenesis imperfect)
Alcoholic (taking more than 40g/day, equals to 100ml 50°Chinese liquor), smoking more than 40 cigarettes/day, or Drug abuser;
Is currently participating in another investigational drug or device study.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Wei Tian
Organizational Affiliation
Beijing Jishuitan Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Anhui Province Hospital
City
Hefei
State/Province
Anhui
ZIP/Postal Code
230088
Country
China
Facility Name
Beijing Jishuitan Hospital
City
Beijing
State/Province
Beijing
ZIP/Postal Code
100035
Country
China
Facility Name
Henan Provincial People's Hospital
City
Zhengzhou
State/Province
Henan
ZIP/Postal Code
450003
Country
China
Facility Name
Jiangxi Provincial People's Hospital
City
Nanchang
State/Province
Jiangxi
ZIP/Postal Code
330006
Country
China
Facility Name
Shanghai Ruijin Hospital
City
Shanghai
State/Province
Shanghai
ZIP/Postal Code
200025
Country
China
Facility Name
Xijing Hospital
City
Xi'an
State/Province
Shanxi
ZIP/Postal Code
710032
Country
China
Facility Name
The First Affiliated Hospital of Xi'an Jiaotong University Medical College
City
Xi'an
State/Province
Shanxi
ZIP/Postal Code
710061
Country
China
Facility Name
The First Affiliated Hospital of Kunming Medical College
City
Kunming
State/Province
Yunnan
ZIP/Postal Code
650032
Country
China
12. IPD Sharing Statement
Learn more about this trial
A Clinical Study of a Spine Fusion System in Vertebral Body Fusion Surgery
We'll reach out to this number within 24 hrs